Which alternative treatments are available for patients who respond poorly to inhaled beta-agonist therapy in the treatment of asthma?

Updated: Jan 07, 2019
  • Author: Michael J Morris, MD, FACP, FCCP; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
  • Print
Answer

Patients who respond poorly or not at all to an inhaled beta-agonist regimen may respond to parenteral beta2 agonists, such as 0.25 mg terbutaline or 0.3 mg of 1:1000 concentration of epinephrine administered subcutaneously. This treatment should be reserved for patients who are seriously ill and not responding to serial treatments with inhaled beta-agonist/anticholinergic therapy and other more established therapies.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!